Ocrevus 300 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FUPYL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,058
Award facts
- Contract value 100% obligated
- $36,057.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of OCREVUS 300 mg/10 mL vials valued at $36,057.84 under a Firm Fixed Price contract type. This delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by September 11, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026.
OCREVUS (ocrelizumab) is a biologic treatment used for multiple sclerosis management, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing need to support military healthcare programs with specialized pharmaceutical products. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and supplies extensive therapeutic categories including specialty medications, vaccines, and medical devices to military and veteran healthcare systems. This delivery order exemplifies the company's role as a primary pharmaceutical provider through its flexible contract vehicle, enabling efficient distribution of essential medications across the Department of Defense healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DB25FUPYL?
SPE2DB25FUPYL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FUPYL worth?
The government has obligated $36,058 on SPE2DB25FUPYL.
Is contract SPE2DB25FUPYL an order under another contract?
Yes. SPE2DB25FUPYL is a delivery order under SPE2DB25D3404, an indefinite delivery contract.
Was contract SPE2DB25FUPYL competed?
The extent of competition for SPE2DB25FUPYL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award